Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Ron DeSantis under fire over fundraiser with Moderna lobbyist

Por: Newsweek Nation June 07, 2023

thumbnail

Ron DeSantis has come under fire from Donald Trump-supporting conservatives after his campaign organized a fundraising event that lists Marc Lampkin, a Moderna lobbyist who was registered as a foreign agent for a Chinese semi-conductor manufacturer, as one of its hosts.The fundraiser, which guests are being charged $1,000 to attend, is taking place on June 23 in downtown Washington D.C.DeSantis formally announced he's standing for the... + full article



Similar News

As demand for COVID shots wanes, biotech superstar Moderna seeks its next success

The Boston Globe USA Business June 23, 2023

thumbnailModerna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.Basking in the accolades heaped on Moderna’s celebrated COVID-19 vaccine, Afeyan regaled the Boston audience with the company’s... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

High school scores and top performers from Friday, March 24 | Orlando Sentinel


Every NBA finals matchup and winner

ESPN USA Sports May 27, 2023

thumbnailA complete list of NBA champions:2022 -- over 2021 -- over 2020 -- over 2019 -- over Golden State Warriors2018 -- Golden State Warriors over 2017 -- Golden State Warriors over Cleveland Cavaliers2016 -- over Golden State Warriors2015 -- Golden State Warriors over Cleveland... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


Moderna’s billionaire CEO reaped nearly $400 million last year. He also got a raise

Portland Press Herald USA World April 30, 2023

thumbnailStéphane Bancel, chief executive of Moderna, had a good year in 2022, exercising stock options that netted him nearly $393 million. The company decided his pay wasn’t good enough. Stephane Bancel The Cambridge, Massachusetts-based biotech, known for its lifesaving coronavirus... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

Moderna’s Covid Boom Is Ending. Why the Outlook Isn’t All Grim. | MarketWatch


As COVID vaccine patent dispute drags on, Moderna forks over $400M to NIH

Ars Technica USA Science February 25, 2023

thumbnailNavigate Filter by topic Settings Front page layout Site theme - Feb 24, 2023 10:40 pm UTC Share this story Vaccine maker Moderna has forked over $400 million to the National Institutes of Health for using a molecular stabilizing technique borrowed from government and academic... + más

Here's what Anthony Fauci's wife actually does at NIH | Fox News

Elon Musk Claims Dr. Fauci’s Wife Oversees Him Ethically, Here’s What Dr. Grady Really Does | Forbes


Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history

CNBC USA Health December 06, 2022

thumbnailVials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop?

Forbes USA Business November 29, 2022

thumbnailGetty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


Moderna sues Pfizer over patents behind COVID-19 vaccine

The Advocate USA Crime October 10, 2022

thumbnailvaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más

Moderna is suing Pfizer over its coronavirus vaccine | The Verge

Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times



About iurex | Privacy Policy | Disclaimer |